Summary:
«Medtronic announced U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm™ AI algorithms for use with the LINQ II™ insertable cardiac monitor (ICM) – and the presentation of AccuRhythm AI validation data this week at Heart Rhythm 2021.»
Article written by Fred Pennic.
30|07|2021
Source:
Hit Consultant
https://hitconsultant.net/2021/07/30/medtronic-fda-clearance-2-ai-algorithms/#.YQvuzC0RpQJ